KLA Corporation enters the week of October 30 earnings with a peculiar setup: the stock has bounced 12% in a week, yet short sellers are barely flinching — and the options market is actually turning less defensive, not more.
The most striking tension is between the price action and the short interest level. KLAC closed at $188.32, up 12% on the week and 2.4% on the day. That is a sharp recovery. Yet short interest remains at a genuinely elevated 22.1% of free float — roughly 29 million shares — and has barely moved, down just 2.5% over the week. Short sellers are not covering into strength. They built positions aggressively in early September, with shares short jumping from around 24 million to nearly 30 million between September 8 and 11 in a matter of days, and that new positioning is holding. The ORTEX short score of 31.8 is stable and unimpressive — this is not a crowded squeeze candidate, but 22% short interest is a genuinely significant structural overhang for a large-cap semiconductor equipment name.
The lending market offers no squeeze pressure whatsoever. Borrow availability is essentially unlimited — ORTEX shows availability at the ceiling of its scale, meaning there are multiples of shares-available-to-borrow versus shares-already-borrowed. That is about as loose as a lending market gets. Cost to borrow has fallen 37% on the week to just 0.32%, a 30-day low. New shorts can enter at almost no incremental cost, which helps explain why the position isn't being unwound despite the rally. The options market adds a different layer: the put/call ratio has dropped to 1.36, nearly 1.7 standard deviations below its 20-day mean of 1.47. That is the lowest PCR reading in several months for KLAC. Options traders are actually reducing defensive positioning — fewer puts relative to calls — even as the stock bounces toward a contested level.
The analyst picture is split, and the most recent actions point toward a measured reset of expectations rather than conviction either way. UBS, the freshest move (September 1), cut its target to $200 while holding Neutral — that target sits just 6% above the current price, signalling little enthusiasm from the sidelines. The cluster of post-July earnings actions told a similar story: Wells Fargo, Deutsche Bank, and Susquehanna all trimmed targets, while JP Morgan's Harlan Sur moved in the other direction, raising to $238 on an Overweight. Cantor Fitzgerald held firm at $325 with an Overweight reiteration, but that target is now more than 70% above the current price and looks disconnected from near-term realities. The consensus mean target of $233.77 implies around 24% upside from current levels — plausible on paper, but the stock is down close to 85% year-to-date, and the forward earnings growth score ranks in just the 12th percentile. The bull case — dominant process control share, Orbotech diversification, 2027 demand acceleration from memory and leading-edge — is intact structurally. The bear case is more immediate: TSMC and Samsung production pressures, limited WFE mix exposure, and a valuation that still commands a 29.6x trailing PE and 24.7x EV/EBITDA even after the YTD drawdown.
Insider activity tells a consistent story over the past six weeks. Every transaction on record is a sale, and the aggregate net over 90 days is a disposal of approximately 334,000 shares worth $65 million. CEO Richard Wallace alone sold $12.4 million in mid-September and $17.4 million in August, all under pre-arranged 10b5-1 plans. That latter point matters — planned sales carry far less signal than discretionary ones — but the volume and consistency of insider disposals across the CFO, EVP of Global Services, and divisional president is notable context. It does not suggest insiders are opportunistically loading up ahead of a recovery.
The October 30 earnings print is the immediate focal point. The prior quarter's result was severe — the stock fell 16.3% the next day and was still down 3.9% five days later. With 22% of the float short, borrow freely available, and the CEO selling into the recent bounce, the setup is less about whether KLAC can recover its year-to-date losses and more about whether the October print gives short sellers any reason to reconsider a position that costs them almost nothing to maintain.
See the live data behind this article on ORTEX.
Open KLAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
